Nobuhiro Ooba

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Oral Anticoagulants

Irritable Bowel Syndrome

Left Atrial Appendage

Top Venues

Expert opinion on drug safety

Clinical epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Rie Nakajima, Nobuhiro Ooba, Miwako Kamei, Hajime Hashiba, Choichiro Miyazaki
Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study. Expert opinion on drug safety (2023)
Kiyoshi Kubota, Nobuhiro Ooba
Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population. Clinical epidemiology 14 (2022)
Nobuhiro Ooba, Yoshinori Takahashi, Marina Nagamura, Masao Takahashi, Makoto Ushida, Eiji Kawakami, Masaomi Kimura, Tsugumichi Sato, Junichi Tokuyoshi, Choichiro Miyazaki, Mitsuaki Shimada
Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study. Expert opinion on drug safety 20 (12) (2021)
Nobuhiro Ooba, Rira Iwahashi, Akiko Nogami, Toshimitsu Nakayama, Atsushi Kanno, Naohiro Tochikura, Susumu Ootsuka, Noriyasu Fukuoka
Comparison between high and low potency statins in the incidence of open-angle glaucoma: A retrospective cohort study in Japanese working-age population. PloS one 15 (8) (2020)